Table 2.

Comparison of TS, A4, 11KT and 11OHA4 concentrations at timepoints 1–5 in treatment-naïve CD patients vs controls. Median (IQR) of treatment-naïve CD patients (Tn) vs controls (C) in pmol/L.

Timepoint	TS	P	A4	P	11KT	P	11OHA4	P
1		0.3998		0.0553		0.0002		0.0002
Tn	32.4 (45.8)		280.0 (216.0)		290.2 (206.0)		807.4 (874.1)
C	26.0 (33.9)		146.4 (141.2)		129.2 (136.4)		442.1 (370.9)
2		0.8969		0.2995		0.0004		0.0001
Tn	28.6 (55.6)		208.9 (249.2)		200.0 (235.8)		542.3 (537.9)
C	28.7 (51.7)		130.9 (168.0)		115.9 (111.1)		165.4 (244.5)
3		0.4519		0.7434		0.0036		0.0001
Tn	20.2 (46.6)		160.9 (184.4)		137.2 (163.0)		378.4 (426.5)
C	27.1 (60.8)		145.4 (182.4)		91.34 (79.4)		123.5 (119.2)
4		0.8229		0.2082		0.0001		0.0001
Tn	20.0 (39.2)		179.1 (275.9)		168.3 (209.0)		421.0 (550.0)
C	25.0 (44.9)		113.1 (135.3)		44.2 (64.9)		49.6 (69.4)
5		0.8907		0.0601		0.0001		0.0001
Tn	28.3 (49.8)		198.9 (289.1)		187.2 (187.8)		734.0 (912.6)
C	30.0 (46.1)		116.3 (121.1)		23.6 (44.3)		45.0 (33.9)